Health Trials

Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting

ConditionPrimary Bilary Cirrhosis (PBC)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Leipzig

About this trial

The seladelpar registry will collect real-world data of patients with PBC diagnosis treated with seladelpar in the real-life scenario in Germany and Switzerland.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Diagnosis of PBC according to EASL criteria

Treatment with seladelpar

Written informed consent

Disqualifiers

current or previous participation in a phase I to IV interventional clinical trial for seladelpar treatment of PBC

Pregnancy and breastfeeding

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

100 Participants
are grouped into 1 trial group

Sponsors and collaborators

University of Leipzig

Lead sponsor

Source ClinicalTrials.gov